NO873495L - MONOCLONAL ANTIBODIES AND PEPTIDES THAT CAN BE USED FOR TREATMENT AND DIAGNOSIS OF HIV INFECTIONS. - Google Patents

MONOCLONAL ANTIBODIES AND PEPTIDES THAT CAN BE USED FOR TREATMENT AND DIAGNOSIS OF HIV INFECTIONS.

Info

Publication number
NO873495L
NO873495L NO87873495A NO873495A NO873495L NO 873495 L NO873495 L NO 873495L NO 87873495 A NO87873495 A NO 87873495A NO 873495 A NO873495 A NO 873495A NO 873495 L NO873495 L NO 873495L
Authority
NO
Norway
Prior art keywords
peptides
diagnosis
treatment
monoclonal antibodies
hiv infections
Prior art date
Application number
NO87873495A
Other languages
Norwegian (no)
Other versions
NO300462B1 (en
NO873495D0 (en
Inventor
Mary Kathleen Shriver
Elaine K Thomas
Wesley L Cosand
Larry H Gosting
Edna S Dickinson
Janela Mcclure
George J Todaro
Robert C Nowinski
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of NO873495D0 publication Critical patent/NO873495D0/en
Publication of NO873495L publication Critical patent/NO873495L/en
Publication of NO300462B1 publication Critical patent/NO300462B1/en

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B25/00—Multi-stage pumps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mechanical Engineering (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO873495A 1986-08-20 1987-08-19 Monoclonal antibodies and peptides that can be used to diagnose HIV infections NO300462B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89827386A 1986-08-20 1986-08-20
US4502687A 1987-05-01 1987-05-01
US6799687A 1987-06-29 1987-06-29

Publications (3)

Publication Number Publication Date
NO873495D0 NO873495D0 (en) 1987-08-19
NO873495L true NO873495L (en) 1988-02-22
NO300462B1 NO300462B1 (en) 1997-06-02

Family

ID=27366600

Family Applications (2)

Application Number Title Priority Date Filing Date
NO873495A NO300462B1 (en) 1986-08-20 1987-08-19 Monoclonal antibodies and peptides that can be used to diagnose HIV infections
NO934897A NO302176B1 (en) 1986-08-20 1993-12-29 Process for the preparation of a monoclonal antibody and an antigen

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO934897A NO302176B1 (en) 1986-08-20 1993-12-29 Process for the preparation of a monoclonal antibody and an antigen

Country Status (28)

Country Link
JP (1) JPS6485928A (en)
KR (1) KR920008744B1 (en)
AT (1) AT398080B (en)
AU (1) AU616156B2 (en)
BE (1) BE1000811A4 (en)
CH (1) CH675728A5 (en)
CS (1) CS275838B6 (en)
DE (1) DE3727703A1 (en)
DK (1) DK433087A (en)
ES (1) ES2010727A6 (en)
FI (1) FI873553A (en)
FR (1) FR2603107B1 (en)
GB (1) GB2196634B (en)
GR (1) GR871298B (en)
HU (1) HU214439B (en)
IE (1) IE60671B1 (en)
IL (1) IL83580A (en)
IT (1) IT1222518B (en)
LU (1) LU86972A1 (en)
NL (1) NL8701950A (en)
NO (2) NO300462B1 (en)
NZ (1) NZ221440A (en)
OA (1) OA08652A (en)
PL (1) PL155084B1 (en)
PT (1) PT85567B (en)
SE (1) SE506025C2 (en)
YU (1) YU152587A (en)
ZW (1) ZW15487A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP96A (en) * 1986-06-03 1990-08-12 The Usa Dept Of Commerce Small peptides which inhibit binding to T-4 receptors and act as immunogens.
AU625720B2 (en) * 1987-05-01 1992-07-16 Genetic Systems Corporation Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
US5834599A (en) * 1987-05-29 1998-11-10 Tanox Biosystems, Inc. Immunoconjugates which neutralize HIV-1 infection
US5981278A (en) * 1987-05-29 1999-11-09 Tanox, Inc. Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
EP0366718B1 (en) * 1987-05-29 1995-05-10 Tanox Biosystems, Inc. Monoclonal antibodies neutralizing hiv-1
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
JP2569185B2 (en) * 1988-01-26 1997-01-08 アメリカ合衆国 Synthetic antigen eliciting anti-HIV response
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
IL90048A0 (en) * 1988-04-25 1989-12-15 Merck & Co Inc Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
FR2632310B1 (en) * 1988-06-06 1992-04-10 Pasteur Institut PEPTIDES HAVING PROTECTIVE PROPERTIES OF A PATHOGENIC VIRUS OF THE HIV TYPE IN SENSITIVE CELLS
WO1990003984A1 (en) * 1988-10-03 1990-04-19 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
EP0421626A1 (en) * 1989-09-19 1991-04-10 Merck & Co. Inc. Vaccine for aids and hepatitis B
SE9000333D0 (en) * 1990-01-31 1990-01-31 Britta Wahren MONOCLONAL ANTIBODY
SE468168B (en) * 1990-02-20 1992-11-16 Replico Medical Ab HIV-1, P24 PEPTIDES, DIAGNOSTIC ANTIGENS AND PROCEDURES FOR DIFFERENTIAL DIAGNOSTICS OF PRELIMINARY HIV-1 POSITIVE SERUM TESTS
JPH03271233A (en) * 1990-03-19 1991-12-03 Inst Pasteur Inducement of protective action against virus infection by synergism between peptides cor- responding to virus envelope glycoprotein and neutral epitope of its glycoprotein
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
JPH05310785A (en) * 1991-09-30 1993-11-22 Nitto Denko Corp Hiv-related cyclic peptide and adsorption material obtained by immobilizing the same
DK0960886T3 (en) * 1992-03-27 2004-09-27 Advanced Immuni T Inc Peptide T and related peptides for the treatment of inflammation, including multiple sclerosis
DK2783697T3 (en) * 2005-12-09 2017-04-10 Vectus Biosystems Ltd VIP Fragments and uses thereof
KR101215215B1 (en) 2008-09-02 2012-12-24 니혼도꾸슈도교 가부시키가이샤 Spark Plug

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
ATE86636T1 (en) * 1984-10-18 1993-03-15 Pasteur Institut F ANTIGENS OF HUMAN IMMUNODEFICIENCY VIRUS AND THEIR USES.
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
ATE109512T1 (en) * 1985-04-08 1994-08-15 Genetic Systems Corp EXPRESSION AND DIAGNOSIS USING GAG-ENCODED PEPTIDES IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV.
NZ215867A (en) * 1985-04-19 1989-10-27 Hoffmann La Roche Aids envelope protein, dna vectors and method of production
EP0220273B2 (en) * 1985-04-29 2007-01-17 Bio-Rad Laboratories, Inc. Synthetic antigens for the detection of aids-related disease
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
ATE108022T1 (en) * 1985-10-24 1994-07-15 Southwest Found Biomed Res SYNTHETIC PEPTIDES AND THEIR USE IN DIAGNOSIS AND VACCINATION FOR AIDS AND ARC.
WO1987002988A1 (en) * 1985-11-07 1987-05-21 President And Fellows Of Harvard College T-cell lymphotrophic virus protein and assay
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
DK169582B1 (en) * 1986-06-23 1994-12-12 Squibb Bristol Myers Co Human monoclonal antibody capable of reacting with an epitope on the LAV / HTLV-III envelope glycoprotein gp41, cell lines producing such antibody, pharmaceutical preparation containing the antibody, and method for determining the presence of LAV / HTLV-III in a biological sample. and method for separating specific antigenic determinants of LAV / HTLV-III using ant
EP0525828A3 (en) * 1986-08-01 1993-02-24 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus
AU592258B2 (en) * 1986-12-30 1990-01-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins

Also Published As

Publication number Publication date
HU214439B (en) 1998-03-30
OA08652A (en) 1988-11-30
AT398080B (en) 1994-09-26
DK433087D0 (en) 1987-08-19
CH675728A5 (en) 1990-10-31
CS275838B6 (en) 1992-03-18
FR2603107B1 (en) 1992-04-24
ES2010727A6 (en) 1989-12-01
GR871298B (en) 1988-01-12
FI873553A (en) 1988-02-21
GB8719587D0 (en) 1987-09-23
NO934897L (en) 1993-12-29
NO302176B1 (en) 1998-02-02
DK433087A (en) 1988-02-21
ZW15487A1 (en) 1988-09-14
HUT44619A (en) 1988-03-28
FR2603107A1 (en) 1988-02-26
LU86972A1 (en) 1988-03-02
IT8721678A0 (en) 1987-08-19
IL83580A0 (en) 1988-01-31
CS8706136A2 (en) 1990-08-14
JPS6485928A (en) 1989-03-30
KR920008744B1 (en) 1992-10-09
BE1000811A4 (en) 1989-04-11
PL267401A1 (en) 1988-07-21
YU152587A (en) 1992-09-07
AU616156B2 (en) 1991-10-24
KR890002547A (en) 1989-04-10
SE8703225L (en) 1988-02-21
NZ221440A (en) 1991-11-26
GB2196634A (en) 1988-05-05
IE60671B1 (en) 1994-08-10
ATA208987A (en) 1994-01-15
NO300462B1 (en) 1997-06-02
IT1222518B (en) 1990-09-05
PT85567B (en) 1991-02-08
IL83580A (en) 1992-11-15
DE3727703A1 (en) 1988-05-05
NO934897D0 (en) 1993-12-29
PT85567A (en) 1987-09-01
SE506025C2 (en) 1997-11-03
NL8701950A (en) 1988-03-16
IE872219L (en) 1988-02-20
NO873495D0 (en) 1987-08-19
FI873553A0 (en) 1987-08-17
AU7720187A (en) 1988-05-19
GB2196634B (en) 1991-05-15
PL155084B1 (en) 1991-10-31
SE8703225D0 (en) 1987-08-19

Similar Documents

Publication Publication Date Title
NO873495L (en) MONOCLONAL ANTIBODIES AND PEPTIDES THAT CAN BE USED FOR TREATMENT AND DIAGNOSIS OF HIV INFECTIONS.
NO862899D0 (en) GRANULATED DETERGENTS FOR DETERGENTS, PROCEDURE FOR THE PREPARATION OF THIS AND APPLICATION OF THIS.
NO154905C (en) PROCEDURE FOR THE PREPARATION OF PREPARATIONS FOR THE TREATMENT OF MELANOMES.
NL300144I2 (en) 20-spiroxanes and opened ring E analogues, processes for their preparation, and pharmaceutical preparations thereof.
NO873699D0 (en) POLYPEPTIDE SUITABLE FOR DIMENSION, TREATMENT AND DIAGNOSIS OF AUTOIMMUNE DISEASES SUCH AS ARTICLES.
DE3872754D1 (en) DETECTION OF ANTIBODY HUMAN IMMUNDEFIZIENZ VIRUS.
NO883834D0 (en) PROCEDURE FOR THE MANUFACTURE OF NEW HIV PROTEINS AND PEPTIDES.
NL188185C (en) METHOD FOR THE PREPARATION OF IMMUNOBIOLOGICAL PREPARATIONS FOR THE DIAGNOSIS, PROPHYLAXIC AND / OR TREATMENT OF CANDIDA INFECTIONS, AND METHOD FOR THE PREPARATION OF A SERUM
EP0018976A4 (en) Medical protein hydrolysate and process of using the same.
NO873197D0 (en) STUDY PREPARATION AND PROCEDURE FOR USING THIS.
DE3786173D1 (en) HUMAN MONOCLONAL ANTIBODY AND MEDICINES FOR PROPHYLAXIS AND TREATMENT OF INFECTIOUS DISEASES.
NO874107D0 (en) NEW MONOCLONAL ANTIBODIES AGAINST IFN-OMEGA, PROCEDURE FOR PRODUCING THEREOF AND APPLICATION FOR PURIFICATION AND DETECTION OF IFN-OMEGA.
NO883626L (en) PROCEDURE FOR DIAGNOSIS OF PICKHOUSE AND TEST SET FOR EXECUTING THE PROCEDURE.
ZA883975B (en) Treatment and diagnosis of footrot using the basic protease of b.nodosus
NO871484L (en) PROCEDURE FOR THE PREPARATION OF N- (SULPHONYLMETHYL) FORMAMIDS.
TR23141A (en) OXODIAZOLON TUEREVI THIS PREPARATION PROCESS, AND HERBISID THAT NEEDS IT
DK410888D0 (en) MONOCLONAL ANTIBODIES AND DIAGNOSIS PROCEDURE FOR PHYTOPHTHORA INFECTIONS
NO874487D0 (en) PROCEDURE FOR THE MANUFACTURE OF POELS AND SIMILAR PRODUCTS.
IT8719010A0 (en) TREATMENT PROCEDURE FOR USED FILTER MATERIALS.
DE3886032D1 (en) HIV-1 RELATED POLYPEPTIDES, DIAGNOSTIC SYSTEMS AND TEST METHODS.
NO883987D0 (en) PROCEDURE FOR THE PREPARATION OF N- (SUBSTITUTED ACLYLIDE) CONDENSED BICYCLOYLKYLIDE AND USE THEREOF AS MEDICINES.
NO872633L (en) MONOCLONAL ANTIBODY AGAINST HUMAN PLASMINOGEN, AND PREPARATION OF THEREOF.
NO882836L (en) PROCEDURE FOR CHEMICAL MODIFICATION OF PROTIDES (PROTEINS AND PEPTIDES).
ATE77743T1 (en) TREATMENT OF YEAST INFECTIONS.
NO881610D0 (en) ANTIBODY AND PROCEDURE FOR ITS MANUFACTURING AND USE, SPECIAL FOR DIAGNOSIS.